booster doses – Page 5 – Communicable Diseases Research

An mRNA vaccine to prevent genital herpes

생식기 포진을 예방하는 mRNA 백신

Review

Published on 2022-04-012022-09-12
Journal: Translational research : the journal of laboratory [Category] COVID19(2023년), SARS, 진단,

Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low

COVID-19에 대한 유행성 이하선염: 예방 접종을 받은 사람들은 지역 사회 이용이 낮을 때 취약한 상태로 남아 있습니다.

Article

Published on 2022-03-152022-09-11
Journal: Vaccine [Category] COVID19(2023년), SARS, 변종,

Gauging the Impact of Artificial Intelligence and Mathematical Modeling in Response to the COVID-19 Pandemic: A Systematic Review

COVID-19 팬데믹에 대응하여 인공 지능 및 수학적 모델링의 영향 측정: 체계적인 검토

Article

Published on 2022-03-142022-09-11
Journal: BioMed Research International [Category] SARS, 변종,

[키워드] Accuracy Analysis analyzed ARIMA article articles artificial AstraZeneca AUC B.1.1.7 B.1.617.2 Beta BNT162b2 booster dose booster doses conducted COVID-19 COVID-19 virus data-driven Delta Effect Effectiveness Evolution groups hybrid Impact initial intelligence literature review machine learning models mathematical mitigate modeling Moderna mRNA mRNA-1273 Pfizer-BioNTech Precision Predictive model predictive models Prevent Quality researcher response review selected sensitivity specificity Spread spread of COVID-19 validation cohort viral variant Viral variants virus were used while
[DOI] 10.1155/2022/7731618 PMC 바로가기 [Article Type] Article

Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study

종단 관찰 연구에서 BNT162b2 2회 투여 후 의료 종사자의 면역 반응 지속

Observational Study

Published on 2022-03-042022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 임상, 진단, 치료기술,

[키워드] age All participants Analysis antibody average binding binding antibody BNT162b2 BNT162b2 vaccine booster dose booster doses booster vaccinations Care cellular Cellular immune response Course COVID-19 disease declining described detectable dose Efficacy evaluated Follow-up groups Health Health care Health care worker hospital humoral humoral and cellular immunity humoral immune response immune response immunological Immunological memory individual interferon Interferon-gamma longitudinal mRNA mRNA-based vaccine Neutralizing antibodies obesity observational study of BNT162b2 Older age participant Participants peptide peptides persistence Pfizer Quantitative response response rate resulting SARS-CoV-2 SARS-COV-2 infection second dose semi-quantitative Serological testing shown vaccination Vaccine worker
[DOI] 10.3389/fimmu.2022.839922 PMC 바로가기 [Article Type] Observational Study

Modelling vaccination strategies for COVID-19

COVID-19에 대한 백신 접종 전략 모델링

Article

Published on 2022-03-012022-09-11
Journal: Nature reviews. Immunology [Category] SARS, 변종,

Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?

Article

Published on 2022-02-132022-10-28
Journal: Vaccines [Category] COVID-19,

Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester

BNT162B2 및 AD26.COV2.S COVID-19 백신의 투여 후 면역 원성은 3 분기 동안 임신 한 집단에서 백신

Observational Study

Published on 2022-02-022022-09-01
Journal: Viruses [Category] COVID19(2023년), Fulltext, MERS, SARS, 변종, 임상, 진단,

[키워드] Ad26 Ad26.COV2.S Ad26.COV2.S vaccine administer adverse event adverse events antibody Antibody titer Antibody titers BNT162b2 booster doses Care Characteristics clinical clinical trials Complete COV2.S COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Critical current death determine develop Effectiveness Efficacy evaluate Evidence Fever General population immunogenic immunogenicity incidence of COVID-19 Lymphadenopathy morbidity mother Newborn observational study of BNT162b2 outcome Population Pregnancy pregnancy vaccination pregnant patient pregnant patients pregnant women Prevent receiving reduce Research reveal Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 mutations seronegative patient seronegative patients seropositive significantly higher statistically significant difference Transmission Trial trimester vaccination Vaccine Viral Viral variants women
[DOI] 10.3390/v14020307 PMC 바로가기 [Article Type] Observational Study

Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 – October 2021

2020년 12월 - 2021년 10월 핀란드 의료 종사자를 대상으로 한 Covid-19 백신 효과에 대한 코호트 연구

Article

Published on 2022-01-312022-09-11
Journal: Vaccine [Category] SARS, 변종,

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence – 25 U.S. Jurisdictions, April 4-December 25, 2021

델타 및 오미크론 변이형 출현 기간 동안 추가 접종 여부와 관계없이 백신 접종을 하지 않은 성인 및 완전히 예방 접종을 받은 성인의 COVID-19 발병률 및 사망률 - 25 미국 관할 구역, 2021년 4월 4일-12월 25일

Article

Published on 2022-01-282022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] 변종,

COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis – California and New York, May-November 2021

COVID-19 예방 접종 상태 및 이전 COVID-19 진단에 따른 COVID-19 사례 및 입원 - 캘리포니아 및 뉴욕, 2021년 5월-11월

Article

Published on 2022-01-282022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] 변종,

[키워드] accounted analyzed booster dose booster doses both group both groups cause changed Cohort cohorts completion COVID-19 COVID-19 case COVID-19 diagnosis COVID-19 incidence COVID-19 vaccination death deaths declined delta variant diagnoses Diagnosis diagnosis of COVID-19 Duration of infection eligible Epidemic Epidemiology highest Hospitalization hospitalizations immune evasion Immunity immunization Immunologic Infection infection with SARS-CoV-2 isolates laboratory-confirmed magnitude New New York occurred omicron outcome predominant Prevent previous diagnosis PROTECT public health recommendation Reinfection SARS-COV-2 infection SARS-CoV-2 infections sequenced status study period Surveillance the SARS-CoV-2 three groups vaccination vaccine dose vaccine doses Vaccine-induced immunity variants virus with COVID-19
[DOI] 10.15585/mmwr.mm7104e1 PMC 바로가기 [Article Type] Article